Zurueck zur Suche

Reporte zur Charge UJ582AAA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

3Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
OR 1 PA 1 VA 1

VAERS 2451938

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge UJ582AAA

gering
Staat
OR
Alter
1,0
Geschlecht
F
Eingang
20.09.2022
Impfdatum
12.09.2022
Beginn
12.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

patient received an expired Pentacel, with no reported adverse event; Initial information received on 13-Sep-2022 regarding an unsolicited valid non-serious case received from a physician. This case involves a 1 year old female patient who received an expired diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (VERO)], with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 12-Sep-2022, the patient received suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine injection at a dose of 0.5 ml total (lot UJ582AAA, expiry date: 10-Sep-2022) via unknown route in unknown administration site for immunisation. On 12-Sep-2022 the patient received an expired pentacel, with no reported adverse event (expired product administered) (same day latency). Action taken: Not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2242044

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ582AAA

gering
Staat
PA
Alter
5,0
Geschlecht
M
Eingang
19.04.2022
Impfdatum
21.12.2021
Beginn
21.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Inappropriate schedule of product administration No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient is was overdue for well child check and overdue for vaccines. Pentacle was ordered and administered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
There was no known adverse reaction. Reporting this due to error in administration over the age of 5 years old.
Aktuelle Erkrankungen
none
Vorgeschichte
atopic dermatitis
Andere Medikamente
topical hydrocortisone acetate
Allergien
none
Vorherige Impfungen
-

VAERS 2024391

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ582AAA

gering
Staat
VA
Alter
-
Geschlecht
U
Eingang
11.01.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

reporting DAPTACEL, ADACEL, PENTACEL , IPOL, and FLUZONE QUADRIVALENT PREFILLED SYRINGES at a low of 0C for 17 hours, with no reported adverse event; Initial information received on 04-Jan-2022 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case involves an unknown age and unknown gender patient who reported daptacel, adacel, pentacel , ipol, and fluzone quadrivalent prefilled syringes at a low of 0c for 17 hours, with no reported adverse event while receiving vaccines IPV (VERO) [IPOL], DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL], DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] and DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] and with the use of medical device FLUZONE QUADRIVALENT PRE-FILLED SYRINGE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient started using FLUZONE QUADRIVALENT PRE-FILLED SYRINGE Unknown dosage unknown (lot - U7093AA, 30-Jun-2022). On an unknown date, the patient received a dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE lot C5743AA in unknown administration site. On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot U7093AA via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot UJ582AAA via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect IPV (VERO) lot T1E872M in unknown administration site. On an unknown date the patient developed an event of a non-serious reporting daptacel, adacel, pentacel , ipol, and fluzone quadrivalent prefilled syringes at a low of 0c for 17 hours, with no reported adverse event (product storage error) (unknown latency) after starting use of FLUZONE QUADRIVALENT PRE-FILLED SYRINGE. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (reporting DAPTACEL, ADACEL, PENTACEL , IPOL, and FLUZONE QUADRIVALENT PREFILLED SYRINGES at a low of 0C for 17 hours, with no reported adverse event). At time of reporting, the outcome was Unknown for the event reporting daptacel, adacel, pentacel , ipol, and fluzone quadrivalent prefilled syringes at a low of 0c for 17 hours, with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-